IRIS Accounts Production v25.1.3.33 07007647 Board of Directors Board of Directors 1.10.23 30.9.24 30.9.24 false true false false true false Ordinary Shares 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh070076472023-09-30070076472024-09-30070076472023-10-012024-09-30070076472022-09-30070076472022-10-012023-09-30070076472023-09-3007007647ns15:EnglandWales2023-10-012024-09-3007007647ns14:PoundSterling2023-10-012024-09-3007007647ns10:Director12023-10-012024-09-3007007647ns10:Director22023-10-012024-09-3007007647ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3007007647ns10:SmallEntities2023-10-012024-09-3007007647ns10:AuditExempt-NoAccountantsReport2023-10-012024-09-3007007647ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-3007007647ns10:SmallCompaniesRegimeForAccounts2023-10-012024-09-3007007647ns10:FullAccounts2023-10-012024-09-3007007647ns10:OrdinaryShareClass12023-10-012024-09-3007007647ns10:RegisteredOffice2023-10-012024-09-3007007647ns5:CurrentFinancialInstruments2024-09-3007007647ns5:CurrentFinancialInstruments2023-09-3007007647ns5:Non-currentFinancialInstruments2024-09-3007007647ns5:Non-currentFinancialInstruments2023-09-3007007647ns5:ShareCapital2024-09-3007007647ns5:ShareCapital2023-09-3007007647ns5:RetainedEarningsAccumulatedLosses2024-09-3007007647ns5:RetainedEarningsAccumulatedLosses2023-09-3007007647ns5:LongLeaseholdAssetsns5:LandBuildings2023-09-3007007647ns5:PlantMachinery2023-09-3007007647ns5:FurnitureFittings2023-09-3007007647ns5:ComputerEquipment2023-09-3007007647ns5:LongLeaseholdAssetsns5:LandBuildings2023-10-012024-09-3007007647ns5:PlantMachinery2023-10-012024-09-3007007647ns5:FurnitureFittings2023-10-012024-09-3007007647ns5:ComputerEquipment2023-10-012024-09-3007007647ns5:LongLeaseholdAssetsns5:LandBuildings2024-09-3007007647ns5:PlantMachinery2024-09-3007007647ns5:FurnitureFittings2024-09-3007007647ns5:ComputerEquipment2024-09-3007007647ns5:LongLeaseholdAssetsns5:LandBuildings2023-09-3007007647ns5:PlantMachinery2023-09-3007007647ns5:FurnitureFittings2023-09-3007007647ns5:ComputerEquipment2023-09-3007007647ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-3007007647ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-3007007647ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2024-09-3007007647ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2023-09-3007007647ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-09-3007007647ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2023-09-3007007647ns10:OrdinaryShareClass12024-09-30
REGISTERED NUMBER: 07007647 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 September 2024

for

Derma SKA Limited

Derma SKA Limited (Registered number: 07007647)






Contents of the Financial Statements
for the Year Ended 30 September 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Derma SKA Limited

Company Information
for the Year Ended 30 September 2024







DIRECTORS: M K Baig
S Ditta





REGISTERED OFFICE: 315, Regents Park Road
Finchley Central
London
N3 1DP





REGISTERED NUMBER: 07007647 (England and Wales)






Derma SKA Limited (Registered number: 07007647)

Balance Sheet
30 September 2024

30.9.24 30.9.23
Notes £    £    £   
FIXED ASSETS
Tangible assets 4 571,873 596,918

CURRENT ASSETS
Stocks 5 1,218 1,428
Debtors 6 8,190 -
Cash at bank 33,797 7,686
43,205 9,114
CREDITORS
Amounts falling due within one year 7 143,859 144,196
NET CURRENT LIABILITIES (100,654 ) (135,082 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

471,219

461,836

CREDITORS
Amounts falling due after more than one
year

8

(87,633

)

(109,162

)

PROVISIONS FOR LIABILITIES (48,198 ) (41,383 )
NET ASSETS 335,388 311,291

CAPITAL AND RESERVES
Called up share capital 10 101 101
Retained earnings 335,287 311,190
SHAREHOLDERS' FUNDS 335,388 311,291

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Derma SKA Limited (Registered number: 07007647)

Balance Sheet - continued
30 September 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 19 June 2025 and were signed on its behalf by:




M K Baig - Director



S Ditta - Director


Derma SKA Limited (Registered number: 07007647)

Notes to the Financial Statements
for the Year Ended 30 September 2024

1. STATUTORY INFORMATION

Derma SKA Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant & machinery 20% reducing balance
Fixtures and fittings 25% reducing balance
Office equipment 15% reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Derma SKA Limited (Registered number: 07007647)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2024

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Financial instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

Cash at bank and in hand
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 9 (2023 - 11 ) .

Derma SKA Limited (Registered number: 07007647)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2024

4. TANGIBLE FIXED ASSETS
Fixtures
Long Plant and and Computer
leasehold machinery fittings equipment Totals
£    £    £    £    £   
COST
At 1 October 2023 379,111 414,624 27,336 3,628 824,699
Additions - 22,158 1,327 828 24,313
At 30 September 2024 379,111 436,782 28,663 4,456 849,012
DEPRECIATION
At 1 October 2023 - 215,002 11,697 1,082 227,781
Charge for year - 44,356 4,191 811 49,358
At 30 September 2024 - 259,358 15,888 1,893 277,139
NET BOOK VALUE
At 30 September 2024 379,111 177,424 12,775 2,563 571,873
At 30 September 2023 379,111 199,622 15,639 2,546 596,918

5. STOCKS
30.9.24 30.9.23
£    £   
Stocks 1,218 1,428

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Other debtors 8,190 -

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Bank loans and overdrafts (see note 9) 12,220 29,020
Hire purchase contracts 30,594 30,594
Trade creditors 60,165 39,819
Taxation and social security 40,880 44,422
Other creditors - 341
143,859 144,196

Derma SKA Limited (Registered number: 07007647)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2024

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
30.9.24 30.9.23
£    £   
Bank loans (see note 9) 20,424 29,388
Hire purchase contracts 67,209 79,774
87,633 109,162

9. LOANS

An analysis of the maturity of loans is given below:

30.9.24 30.9.23
£    £   
Amounts falling due within one year or on demand:
Bank loans 12,220 29,020

Amounts falling due between one and two years:
Bank loans - 1-2 years 12,220 12,220

Amounts falling due between two and five years:
Bank loans - 2-5 years 8,204 17,168

10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.9.24 30.9.23
value: £    £   
101 Ordinary Shares £1 101 101